Ariel Brumbaugh, PhD

Ariel Brumbaugh, PhD has worked in a variety of roles in the biosciences since 2002. In 2002, they worked as an Undergraduate Research Assistant in the Department of Chemistry at the University of Washington, assisting with the organic synthesis of non-linear optical materials. In 2004, they were a Trans-Atlantic Science Student Exchange student in Chemistry at the Universidad Complutense de Madrid and a Research in Science and Engineering (RISE) Intern in the Laboratory of J. Herbert Waite, Ph.D. at UC Santa Barbara. From 2006-2008, they worked as a Research Technician in the Laboratory of Derek L. Stirewalt, M.D. at the Fred Hutchinson Cancer Research Center, and as a Doctoral Student and Laboratory Manager in the Laboratories of Victor J. DiRita, Ph.D. and Harry L.T. Mobley, Ph.D. at the University of Michigan, respectively. From 2015-2017, they were a Postdoctoral Research Fellow in the Laboratory of Michael A. Fischbach, Ph.D. at the University of California, San Francisco and Stanford University. From 2019-2021, they were a Consultant for Microbiome Therapeutics and Scientist and Research Team Lead (R&D, Tech Ops) at Federation Bio, where they worked with founders to define the company vision, secure venture capital pre-launch, translate basic science from academia to an industry setting, hire talent, develop a research strategy, build out research operations, conduct preclinical research targeting multiple indications, secure a strong IP position, establish a regulatory plan, fundraise subsequent funding rounds (Seed, Series A), and found a supportive company culture. Ariel currently works as a Biosciences Business Development Manager, Corporate Liaison and Ventures at Gladstone Institutes.

Ariel Brumbaugh, PhD has an extensive education history. From 2001 to 2006, they attended the University of Washington, where they earned a Bachelor of Science (B.S.) in Biochemistry. From 2009 to 2014, they attended the University of Michigan, where they earned a Doctor of Philosophy (Ph.D.) in Microbiology and Immunology. From 2015 to 2017, they attended the University of California, San Francisco, where they were a Postdoctoral Associate in the Department of Bioengineering and Therapeutic Sciences. Finally, from 2017 to 2019, they attended Stanford University, where they were a Postdoctoral Associate in Bioengineering.